SBS30 · GRCh37 · COSMIC v93

Mutational profile

Mutational profile using the conventional 96 mutation type classification. This classification is based on the six substitution subtypes: C>A, C>G, C>T, T>A, T>C, and T>G, as well as the nucleotides immediately 5’ and 3’ to the mutation.

Each of the substitutions is referred to by the pyrimidine of the mutated Watson—Crick base pair. Incorporating information on the bases immediately 5’ and 3’ to each mutated base generates 96 possible mutation types (6 types of substitution x 4 types of 5’ base x 4 types of 3’ base). Mutational signatures are displayed and reported based on the observed trinucleotide frequency of the genome, i.e., representing the relative proportions of mutations generated by each signature based on the actual trinucleotide frequencies of the corresponding reference genome.

v3.2_SBS30_PROFILE_GA_GRCh37.jpg

Genome: GRCh37

Proposed aetiology

SBS30 is due to deficiency in base excision repair due to inactivating mutations in NTHL1.

Acceptance criteria

Summary of the technical and experimental evidence available in the scientific literature regarding the validation of the mutational signature.

Supporting evidence for mutational signature validity

Validated evidence for real signature
Unclear evidence for real signature
Evidence for artefact signature
Background Identification study First included in COSMIC
Alexandrov et al. 2015 Nature Genetics / Nik-Zainal et al. 2016 Nature v2
Identification NGS technique Different variant callers Multiple sequencing centres
WES & WGS Yes Yes
Technical validation Validated in orthogonal techniques Replicated in additional studies Extended context enrichment
Yes Yes -
Proposed aetiology Mutational process Support
BER deficiency Experimental confirmation
Experimental validation Experimental study Species
Drost et al. 2017 Science Human

Tissue distribution

Numbers of mutations per megabase attributed to each mutational signature in human cancer samples where the signature is present.

Only those cancer types with tumors in which signature activity is attributed are shown. The numbers below the dots for each cancer type indicate the number of tumors in which the signature was attributed (above the blue horizontal bar) and the total number of tumors analysed (below the blue bar). Only high confidence data is displayed (samples with ≥10 mutations and >0.90 reconstruction accuracy).

v3.2_SBS30_TISSUE.jpg

Transcriptional strand bias

v3.2_SBS30_STRAND_BIAS.jpg

Differences between current and previous profiles

The cosine similarity between the prior and current versions of signature SBS30 is 0.96.

v3.2_SBS30_DIFFERENCE_GA_GRCh37.jpg

Genome: GRCh37